The Ozempic Conversation
The arrival of Ozempic, Wegovy and other semaglutides have sent shockwaves across the CPG space.
Are they a threat? Will they become mainstream? How should brands react?
In this report we analyze 116+ million consumer posts from the Food, Beverage and Supplements categories to explore the impact of semaglutides on eating and drinking.
What’s inside?
- What semaglutide users are eating, drinking and avoiding
- The impact on consumer behavior and the opportunities/dangers for brands
- 5 emerging cross-category need-spaces
